SCHEMBL25013

SCHEMBL25013

CC(OC(=O)c1ccccc1)OC(=O)C(N)C1(CC(=O)O)CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
SCN1A P35498 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN3A Q9NY46 1/20 0.41
APOBEC3A P31941 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
POLB P06746 2/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27641457 0.86 ADRB2 (0.43) LMNACYP1A2CYP2D6SCN1ASCN2A
SCHEMBL4756232 0.85 TP53 (0.38) LMNACYP1A2CYP2D6SCN1ASCN2A
SCHEMBL4756193 0.84 LMNA (0.36) LMNACYP1A2CYP2D6SCN1ASCN2A
SCHEMBL6884986 0.84 TP53 (0.37) LMNACYP1A2CYP2D6SCN1ASCN2A
SCHEMBL3398321 0.84 USP2 (0.37) LMNACYP1A2APOBEC3AAPOBEC3GTSHR
SCHEMBL1563267 0.84 USP2 (0.37) LMNACYP1A2APOBEC3AAPOBEC3GTSHR
SCHEMBL4697046 0.82 LMNA (0.41) LMNACYP1A2CYP2D6SCN1ASCN2A
SCHEMBL5147376 0.81 CYP2D6 (0.36) LMNACYP1A2CYP2D6SCN1ASCN2A
SCHEMBL3182386 0.81 SMN1; SMN2 (0.35) LMNACYP1A2APOBEC3AAPOBEC3GTSHR
SCHEMBL27622479 0.79 CYP2D6 (0.40) LMNACYP1A2CYP2D6SCN1ASCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902714-B1 Prodrugs of gaba analogs, compositions and uses thereof XENOPORT INC (US) 2012-01-11 EP disclosed
WO-2008157408-A2 USE OF PRODRUGS OF GABA ANALOGS, ANTISPASTICITY AGENTS, AND PRODRUGS OF GABA B RECEPTOR AGONISTS FOR TREATING SPASTICITY XENOPORT, INC. (US) 2008-12-24 WO disclosed